Posted by AGORACOM-JC
at 8:23 AM on Monday, February 1st, 2021
Announced that it has completed its corporate name change
The Company’s CSE ticker symbol “KNR”, OTC Markets ticker symbol “KNRLF”, and Frankfurt Stock Exchange ticker symbol “1K8” will remain unchanged.
The Company’s common shares are expected to resume trading on the CSE under the name “Kontrol Technologies Corp.” on or about February 5, 2021.
TORONTO, ON / February 1, 2021 / Kontrol Technologies Corp. (formerly Kontrol Energy Corp.) (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company“), is pleased to announce that it has completed its corporate name change (the “Name Change“) and continuation out of the Province of British Columbia under the provisions of the Business Corporations Act (British Columbia) into the Province of Ontario under the provisions of the Business Corporations Act (Ontario) (the “Continuance“), as approved by the shareholders of the Company at the Annual General and Special Meeting held on August 28, 2020. Copies of the certificate of continuation and the articles will be filed under the Company’s profile at www.sedar.com and www.thecse.com. There will be no change in the day-to-day business of the Company as a result of the Continuance.
The Company’s CSE ticker symbol “KNR”, OTC Markets ticker symbol “KNRLF”, and Frankfurt Stock Exchange ticker symbol “1K8” will remain unchanged. The Company’s common shares are expected to resume trading on the CSE under the name “Kontrol Technologies Corp.” on or about February 5, 2021. Trading under the name “Kontrol Technologies Corp.” is subject to approval from the Canadian Securities Exchange (CSE) and receipt of new CUSIP and ISIN numbers. The Company will update the market of the effective date of the name change once available.
“The name change to Kontrol Technologies Corp. better reflects our future and our brand,” says Paul Ghezzi, CEO of Kontrol. “We look forward to advancing our energy management, GHG emission and viral detection technologies, which form the foundation of our smart buildings and smart cities solutions.”
Kontrol Energy Group Inc. remains an operating subsidiary of Kontrol Technologies Corp.
Posted by AGORACOM-JC
at 8:16 AM on Monday, February 1st, 2021
Announce that Masa Ishimitsu has joined the Company as an Advisor to the CEO for the purposes of launching ImagineAR platform marketing and sales in Japan .
Mr. Ishimitsu is a former President of major companies in Japan including Solo Cup Japan & Asia Pacific Limited, SPXFlow Technology Japan, and Misawa Homes of America .
ImagineAR believes Mr. Ishimitsu will significantly accelerate the Company’s presence and sales throughout Japan and the Far East.
VANCOUVER, BC , Feb. 1, 2021 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, brands and businesses to instantly create their own mobile phone AR campaigns, is pleased to announce that Masa Ishimitsu has joined the Company as an Advisor to the CEO for the purposes of launching ImagineAR platform marketing and sales in Japan . Mr. Ishimitsu is a former President of major companies in Japan including Solo Cup Japan & Asia Pacific Limited, SPXFlow Technology Japan, and Misawa Homes of America . ImagineAR believes Mr. Ishimitsu will significantly accelerate the Company’s presence and sales throughout Japan and the Far East.
Masa Ishimitsu said “ImagineAR is the most advanced AR platform in the market today and I am excited to launch the company’s sales and marketing initiatives in Japan . Its simple platform means that organizations can almost instantly start engaging their customers and fans at a time when recovery and renewed market positions are essential. As consumers are slowly returning to stores and sports are coming back, information, offers and simple engagement will need to be more dynamic and shareable.”
Mr. Ishimitsu continued “ImagineAR lets marketing ideas get creative and conversations around brands to escalate, enabling experimentation at value and speed unlike other current AR solutions. AR industry in Japan is still at a very early stage of development and this means potentially a great opportunity for ImagineAR to capture market share. Also, Canada is my second home as I am a graduate of high school and the University in Victoria , B,C.. Having spent over 35 years in the international business, together with my bilingual and bicultural background, I am truly excited to be a part of Imagine AR’s team to develop the business in Japan .”
“Mr. Ishimitsu brings an impressive track record of success with major international companies expanding into Japan ,” said Alen Paul Silverrstieen, CEO and President of Imagine AR. “ImagineAR will continue our aggressive global expansion this year.”
This press release is available on the Company’s AGORACOM Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
Posted by AGORACOM-JC
at 8:05 AM on Monday, February 1st, 2021
Awarded a long-term COVID-19 testing and healthcare management program for the Dallas Market Center, the leading wholesale marketplace in North America and the most complete wholesale trade resource in the world.
DMC is a five million square foot, global business-to-business trade center and the leading wholesale marketplace in North America connecting retailers and interior designers with top manufacturers in home décor, furniture, gifts, lighting and fashion.
VANCOUVER BC / February 1, 2021 / EMPOWER CLINICS INC. (CBDT:CSE) (EPWCF:OTCQB) (8EC:Frankfurt) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens each month, developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce that KAI Medical Laboratory has been awarded a long-term COVID-19 testing and healthcare management program for the Dallas Market Center (“DMC”), the leading wholesale marketplace in North America and the most complete wholesale trade resource in the world.
KAI TO PROVIDE DAILY ONSITE COVID TESTING TO KEEP FIVE MILLION SQUARE FOOT TRADE CENTER OPEN TO BUYERS AND SELLERS FROM AROUND THE WORLD
DMC is a five million square foot, global business-to-business trade center and the leading wholesale marketplace in North America connecting retailers and interior designers with top manufacturers in home décor, furniture, gifts, lighting and fashion. DMC markets events throughout the year attracting buyers and sellers from all 50 states and more than 80 countries, resulting in significant economic impact:
$8 Billion in annual wholesale transactions
$1.1 Billion in indirect local economic impact
$380 million in direct local economic impact
“We cannot recover from crises like the COVID-19 pandemic without a resilient retail sector and the market centers have a critical role in participating in that recovery,” said Harlan Crow, chairman of the company that owns DMC in a January 3, 2021 Forbes Article.
Tags: covid19, Covid19 testing, CSE, Diagnos Inc, investments, Kai Medical Laboratory Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca $EPWCF Subsidiary KAI Medical Laboratory Awarded #COVID-19 Testing & Healthcare Management Program for Five Million Square Foot Dallas Market Center, The Most Complete Wholesale Trade Resource in The World With $8 Billion USD In Annual Transactions $WELL.ca $DOC.ca $DOCRF $VMD.ca
Posted by AGORACOM-JC
at 7:59 AM on Monday, February 1st, 2021
Received a Purchase Order from a Canadian mining company for COVID-19 test kits manufactured by 1drop Inc., and ancillary products.
The total gross sales amount of the sales is approximately $250,000 CAD, excluding shipping and courier fees.
This brings approximately $2.8M sales to date to the Canadian mining companies.
Toronto, Ontario–(February 1, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”), is pleased to announce that it has received a Purchase Order (the “PO”) from a Canadian mining company (the “Purchaser”) for COVID-19 test kits manufactured by 1drop Inc. (“1drop”), and ancillary products. The total gross sales amount of the sales is approximately $250,000 CAD, excluding shipping and courier fees. This brings approximately $2.8M sales to date to the Canadian mining companies.
Under the terms of the sale to the Purchaser, Datametrex will provide 1drop COVID-19 qPCR Detection Kits, a PCR machine, an RNA extraction machine, and RNA extraction kits. Datametrex anticipates that it has a little or no upfront costs associated with the sale of the test kits. All of the items are shipped directly from manufacturers to the purchaser’s mine operating sites.
“This further confirms Datametrex’s approach with its diverse COVID-19 product portfolio of health security products and services,” stated Marshall Gunter, CEO of Datametrex.
Posted by AGORACOM-JC
at 7:58 PM on Sunday, January 31st, 2021
Beyond Meat has become an $11 BILLION company by creating products designed to emulate beef. The basis of success has come from delivering the experience meat eaters have come to love (hamburgers, hot dogs, etc.) while also achieving the goal of eating healthier.
TAAT™ Beyond Tobacco™ mimics the experiences of cigarettes without nicotine or tobacco. It is engineered to closely emulate the sensory components of smoking a tobacco cigarette, including tasting and smelling just like tobacco.
E-cigarettes and vaping have failed despite existing for 15 years, driving most smokers back to cigarettes because they only perpetuate the problem of nicotine addiction while delivering a completely different user experience to smokers.
Under the leadership of experienced veterans from the tobacco industry, including and especially Philip Morris International, TAAT™ launched in the United States Just 7 weeks ago and has already received repeat orders from more than 60% of convenience and gas station customers.
How good was this launch?
“Out of all of the tobacco category products I have worked with, TAAT™ is an outlier in terms of the level of demand it has had in its early stages. I have launched dozens of new tobacco brands across Canada as well as in the Caribbean, and while many of the new products were reordered by retailers in their first several weeks on the market, none of them were reordered by anywhere near 60% of stores that initially carried them. …. I have confidence that we could replicate these outcomes both in Ohio and in other markets where we may introduce TAAT™ in the future.” – TAAT Chief Revenue Officer Tim Corkum (former commercialization executive for Philip Morris International)
How big is the market TAAT is going after? Tobacco is used by:
34M adults in America, equating to 215 BILLION cigarettes sold in 2018
1.3 billion people worldwide
… and almost all of them aspire to leave nicotine behind. Beyond Tobacco™ from TAAT is about to give them what they want and, if they succeed, give shareholders “Beyond Belief” returns in the next 2-3 years.
Watch this great interview with CEO Setti Coscarella!
Posted by AGORACOM-JC
at 7:42 PM on Sunday, January 31st, 2021
Hollister Biosciences (HOLL:CSE) is a multi-state operator with multiple, high-quality products that are now carried in over 280 dispensaries throughout California and over 90 dispensaries throughout Arizona.
Q4 Highlights:
Record quarterly revenue of CDN$14.93 million and CDN$2.53 million in EBITDA
Venom Extracts is their 100% owned subsidiary that is absolutely dominating the state of Arizona. More than just lip service:
Since the closing (Venom), in the three quarters following, Venom contributed approximately CDN$38 million to the company’s 2020 revenue.
In the entire year of 2020,
Venom generated greater than CDN$ 40 million in revenue (and CDN$ 4.9 million in adjusted EBITDA),
Up from CDN$ 16.4 million in 2019 a 144% year over year revenue increase, and ending the year with a record month of sales for December totaling approximately CDN$5.5 million .
Sold over 4 million grams of product in 2020
accounting for up to 30 percent of category sales statewide in Arizona .
Positioned for continued growth in Arizona with the recently passed adult-use legislation
Marijuana Business Daily projects that Arizona’s recreational market could generate up to $400 million in revenue its first year and more than $700 million by 2024.
….. And it is run by the absolute coolest guy in small cap Cannabis – Jake Cohen
Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca
Posted by AGORACOM-JC
at 9:31 AM on Friday, January 29th, 2021
Added former banking executive, Dana Ades-Landy to its Board of Directors
Over 25 years of experience in strategic development, governance and advocacy in the banking and financial services sector.
Experience includes: Senior positions at National Bank, KPMG, Laurentian Bank
Montreal, Quebec–(January 29, 2021) – Peak Fintech Group Inc. (CSE: PKK) (OTCQX: PKKFF) (“Peak” or the “Company”), an innovative Fintech service provider to the Chinese commercial lending sector, today announced that it has added former banking executive, Dana Ades-Landy to its Board of Directors.
Ms. Ades-Landy has over 25 years of experience in strategic development, governance and advocacy in the banking and financial services sector. She is currently in her second tour of duty with the National Bank of Canada where she works with the bank’s special loans group, managing a diverse portfolio of commercial and corporate clients while providing coaching and mentoring to the group’s less seasoned members. She first worked at the National Bank of Canada from 1993 to 2004 occupying various management and executive positions, culminating with the position of Vice-President, Credit Risk and Specialized Products.
Ms. Ades-Landy spent 3 years at KPMG as a Senior Vice-President and Associate providing the firm’s corporate clients with advice in the fields of insolvency, restructuring, turnaround, and business revitalization. She left KPMG in 2006 and went on to spend the following 10 years holding Senior Vice-President and Vice-President positions at the Laurentian Bank of Canada and Scotia Bank, respectively, before serving as CEO of the Quebec chapter of the Heart and Stroke Foundation of Canada from 2016 to August 2020.
Posted by AGORACOM-JC
at 8:15 AM on Friday, January 29th, 2021
Conference highlights industry leaders and innovators in the psychedelic therapy space and features Michael Pollan, author of New York Times bestseller, “How to Change Your Mind”
Will present at Canaccord Genuity’s “New Paradigms & Treatment Approaches in Mental Health” conference on February 3rd and 4th, 2021.
Two-day virtual conference will explore the science, intellectual property, and legality of psychedelic compounds, which are at the forefront of breakthrough medical science.
Novamind’s CEO and Director, Yaron Conforti will present on Wednesday February 3rd from 1:30-1:55 PM.
TORONTO, ON / January 29, 2021 / Novamind Inc. (CSE:NM) (“Novamind”), a mental health company specialized in psychedelic medicine, today announced that it will present at Canaccord Genuity’s “New Paradigms & Treatment Approaches in Mental Health” conference on February 3rd and 4th, 2021.
The two-day virtual conference will explore the science, intellectual property, and legality of psychedelic compounds, which are at the forefront of breakthrough medical science. Novamind’s CEO and Director, Yaron Conforti will present on Wednesday February 3rd from 1:30-1:55 PM.
Novamind, which has administered over 5,000 ketamine therapy treatments since 2016 and hosted over 20,000 client visits to its clinics in 2020 alone, will share its vision for scaling access to psychedelic medicine and advancing clinical research.
The conference will also feature keynote speaker Michael Pollan, author of the #1 New York Times bestseller “How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence.”
For more information about the conference, please click here.
